ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
bedger
|
517 |
126K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
517
|
126K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
bedger
|
18K |
6.9M |
17 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
18K
|
6.9M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
bedger
|
317 |
140K |
2 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
317
|
140K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
29K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
142
|
29K
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
29K |
7 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
142
|
29K
|
7
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
29K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
142
|
29K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
29K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
142
|
29K
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
bedger
|
1.5K |
381K |
15 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.5K
|
381K
|
15
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
454 |
159K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
454
|
159K
|
4
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
bedger
|
1.5K |
381K |
17 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.5K
|
381K
|
17
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
bedger
|
1.7K |
542K |
11 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.7K
|
542K
|
11
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
bedger
|
1.5K |
381K |
17 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.5K
|
381K
|
17
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
bedger
|
30 |
11K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
11K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
bedger
|
30 |
11K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
bedger
|
30 |
11K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
11K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
In Kiwi land we eagerly await "The bedger Report" on Zip
|
|
bedger
|
23 |
4.8K |
13 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
23
|
4.8K
|
13
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
454 |
159K |
18 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
454
|
159K
|
18
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
454 |
159K |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
454
|
159K
|
1
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
454 |
159K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
454
|
159K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
bedger
|
10K |
3.3M |
35 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
35
|
|
ASX - By Stock
|
ZIP |
Re:
ZIP's coming 1Q FY24 Trading Update
|
|
bedger
|
275 |
57K |
15 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
275
|
57K
|
15
|
|
ASX - By Stock
|
ZIP |
Re:
ZIP's coming 1Q FY24 Trading Update
|
|
bedger
|
275 |
57K |
11 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
275
|
57K
|
11
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
21K |
4 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
66
|
21K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
609 |
205K |
17 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
609
|
205K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
bedger
|
139 |
40K |
26 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
139
|
40K
|
26
|
|
ASX - By Stock
|
ASM |
Re:
Relevant Media
|
|
bedger
|
3.4K |
1.3M |
11 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
3.4K
|
1.3M
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
bedger
|
18 |
5.1K |
18 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
18
|
5.1K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
bedger
|
317 |
140K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
317
|
140K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
bedger
|
3.1K |
670K |
9 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
3.1K
|
670K
|
9
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
bedger
|
3.1K |
670K |
8 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
3.1K
|
670K
|
8
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
bedger
|
3.1K |
670K |
11 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
3.1K
|
670K
|
11
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
21K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
66
|
21K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
bedger
|
27 |
9.1K |
24 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
27
|
9.1K
|
24
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
21K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
66
|
21K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
21K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
66
|
21K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
21K |
6 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
66
|
21K
|
6
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
21K |
3 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
66
|
21K
|
3
|
|
ASX - By Stock
|
HAS |
Re:
Ann: JL MAG to Become 9.8% Strategic Investor in Hastings
|
|
bedger
|
27 |
15K |
7 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
27
|
15K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
bedger
|
34 |
9.0K |
5 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.0K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
bedger
|
34 |
9.0K |
22 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.0K
|
22
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Record Quarterly and Yearly Revenue Show Outstanding Growth
|
|
bedger
|
34 |
8.1K |
11 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
34
|
8.1K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
609 |
205K |
17 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
609
|
205K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
bedger
|
706 |
255K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
706
|
255K
|
4
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Arafura confirms German ECA support with Euler Hermes
|
|
bedger
|
34 |
16K |
6 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
34
|
16K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata to Acquire IP from Tekcyte
|
|
bedger
|
73 |
16K |
7 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
73
|
16K
|
7
|
|
ASX - By Stock
|
ARU |
Re:
Arafura Rare Earths Ltd
|
|
bedger
|
1.1K |
522K |
14 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
1.1K
|
522K
|
14
|
|
ASX - By Stock
|
ASM |
Re:
Relevant Media
|
|
bedger
|
3.4K |
1.3M |
5 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
3.4K
|
1.3M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene onCARlytics Doses First Patient in IV Combination
|
|
bedger
|
211 |
92K |
22 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
211
|
92K
|
22
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
614 |
116K |
1 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
614
|
116K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
614 |
116K |
5 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
614
|
116K
|
5
|
|